Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × ADI PEG20 × Clear all

NCT06034977 2023-09-13

Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT00056992 2015-03-25

Testing of ADI-PEG in Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular